Angiotensin II and transforming growth factor β affect cardiovascular and renal disease in patients with type 2 diabetes mellitus: benefits of dpp-4 inhibitors treatment

Por Teona A. Shvangiradze, Irina Z. Bondarenko, Ekaterina A. Troshina, Marina V. Shestakova, Larisa V. Nikankina, Natalia S. Fedorova
Publicado em 2019-12-01

TGF-β and FRF-21: association with coronary artery disease in patients with type 2 diabetes and obesity

Por Teona A. Shvangiradze, Irina Z. Bondarenko, Ekaterina A. Troshina, Larisa V. Nikankina, Svetlana S. Kukharenko, Marina V. Shestakova
Publicado em 2017-11-01

Profile of microRNAs associated with coronary heart disease in patients with type 2 diabetes

Por Teona A Shvangiradze, Irina Z Bondarenko, Ekaterina A Troshina, Marina V Shestakova, Alexander V Ilyin, Larisa V Nikankina, Aleksandr V Karpukhin, Tat'yana A Muzaffarova, Fatimat M Kipkeeva, Kristina A Grishina, Anna Yu Kuzevanova
Publicado em 2016-12-01